Cite Filings / DMRA / 0001193125-26-010366

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Damora Therapeutics, Inc. Filed 2026-01-12 Acc 0001193125-26-010366

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-12 8-K Regulation FD disclosure
2026-01-07 4 Chief Medical Officer acquired 264,629 shares (grant or award)
2026-01-07 3 Initial Statement of Ownership
2026-01-06 4 Chief Executive Officer sold 700 shares at $21.38 ($14,966)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…